This report provides an update on a series of topics focusing on substance use and mental health (collectively referred to as behavioral health) in the United States. SAMHSA selected specific topics and indicators in this report to represent a cross-section of the key behavioral health indicators that are assessed in SAMHSA data collections, including NSDUH. This report is intended to provide a concise, reader-friendly summary of key behavioral health measures for lay and professional audiences.

This manual lists examples of brief intervention and brief treatment for alcohol and drug misuse. It offers criteria for providing brief therapy and longer-term treatment. The manual also provides sample brief-assessment instruments, and lists other professionals who can provide brief interventions.

This guide provides strategies for clinicians who provide substance use disorder treatment to people who have experienced child abuse and child neglect. It lists symptoms of child abuse and neglect and presents screening questions, behavioral clues, and the role of child protective services.

This manual gives an overview of trauma and outlines principles of trauma-informed care. It describes the types, characteristics, and common experiences of trauma.

This guide provides clinicians with treatment, screening, and intervention tools to address the needs of men in recovery.

This guide provides practical information to clinicians and other professional care providers who treat women living with substance use disorders. It addresses risk factors, mental illness and substance use screening, patient assessment, treatment, and relapse.

This manual serves as a quick reference guide for clinicians treating chronic pain in adults living with a history of substance use. It covers patient assessment and treatment, and provides an algorithm for managing chronic pain, as well as a summary of non-opioid analgesics.

This guide informs clinicians about medications for opioid use disorder treatment, including side effects, drug interactions, and take-home doses. It discusses patient counseling, associated medical issues, hepatitis C evaluation, drug testing, and pregnant women.